Figure 4.

Antioxidant versus pro-oxidant capacity of TAA-induced versus human MNCs-treated rats. a) MDA level was significantly (p < 0.05) elevated in TAA-induced rats versus control (at 0 time). MNCs injection improved the TAA-induced oxidative stress as indicated by significant reduction (p < 0.05) in MDA level at weeks 22 and 24. c) Marked reduction in GSH was observed followed by human elevation in GSH level after MNCs treatment induced significant, b, d, and e) Catalase, GST and GPx activities in TAA-induced were reduced (p<0.05). Treatment of rats with cirrhotic liver by injection of human MNCs, increased the antioxidant enzymes activities significantly (p <0.05). The statistical significance was indicated by *from control and **between MNCs-treated versus mock-treated rats.